Featured
Read our handpicked blogs, curated for you.
|
The risk landscape for global finance has moved beyond simple predictive modeling. For years, AI for risk management in…
|
The landscape of financial crime has entered a new era of technical sophistication. For years, AI for fraud detection…
|
The Evolution of Banking Data QualityThe first generation of banking data quality tools relied on rigid, rules-based…
Recent releases
|
Proving Marketing ROI to the Board with Engagement Data
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If your team is still defending budgets with vanity metrics, you lose ground.…
|
Veeva vs Modular CMS: Which Is Better for Pharma Content Approvals?
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the content approval cycle drags on for weeks, sometimes months. Every delay costs…
|
HCP Engagement Analytics & Metrics Every Pharma CMO Must Track
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to know not just if doctors were contacted, but whether those interactions drove…
|
How to Prove ROI of Your Pharma Marketing Budget in India
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance demands have grown tighter. Yet, proving the ROI of a pharma marketing budget remains…
